Pott’s Disease Caused by Mycobacterium bovis Following Intravesical BCG Therapy for Bladder Cancer
Sign Up to like & getrecommendations! Published in 2017 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofx163.1807
Abstract: Abstract Background Bacillus Calmette-Guerin (BCG) are attenuated strains of Mycobacterium bovis, which is part of the Mycobacterium tuberculosis complex. BCG is used for bladder cancer therapy. Case/Methods 80 year old man presented with severe back… read more here.
Keywords: bcg therapy; bladder cancer; bladder;
Re: Disseminated Mycobacterium bovis Infection Post-Kidney Transplant following Remote Intravesical BCG Therapy for Bladder Cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Urology"
DOI: 10.1097/ju.0000000000000381
Abstract: available at http://www.ncbi.nlm.nih.gov/pubmed/29809299 Editorial Comment: A rare and potentially fatal complication of intravesical bacillus Calmette-Gu erin (BCG) therapy is BCG induced sepsis. Historically BCG was not recommended in patients in any type of immunocompromised state… read more here.
Keywords: mycobacterium bovis; therapy; bcg therapy; disseminated mycobacterium ... See more keywords
MP73-05 BCG-UNRESPONSIVE NMIBC, COMPARISON OF 2 ND -LINE INTRAVESICAL INSTILLATION THERAPY
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Urology"
DOI: 10.1097/ju.0000000000000959.05
Abstract: INTRODUCTION AND OBJECTIVE: Intravesical Bacillus Calmette-Guerin (BCG) immunotherapy is the gold-standard treatment for high-risk non-muscle-invasive bladder cancer (NMIBC), while over 30% patients experience tumor recurrence following BCG therapy. We aimed to screen for reliable circulating… read more here.
Keywords: therapy; following bcg; bcg therapy; bcg ... See more keywords
Contemporary Outcomes of Patients with Non-Muscle Invasive Bladder Cancer Treated with BCG Therapy: Implications for Clinical Trial Design.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Urology"
DOI: 10.1097/ju.0000000000001633
Abstract: PURPOSE Recurrent disease after BCG presents a therapeutic challenge. To aid trial development, the US Food & Drug Administration defined 'adequate BCG' therapy and adopted the 'BCG unresponsive' disease state. Available data for efficacy benchmark… read more here.
Keywords: muscle; bcg therapy; cancer; adequate bcg ... See more keywords
Bacille Calmette-Guérin (BCG) spondylitis with adjacent mycotic aortic aneurysm after intravesical BCG therapy: a case report and literature review
Sign Up to like & getrecommendations! Published in 2018 at "BMC Infectious Diseases"
DOI: 10.1186/s12879-018-3205-7
Abstract: BackgroundAlthough intravesical bacille Calmette-Guérin (BCG) therapy is accepted as an effective treatment for bladder cancer, serious complications may occur in rare cases. To date, only 4 cases have been reported in which the patient developed… read more here.
Keywords: bcg therapy; case; bcg spondylitis; therapy ... See more keywords
Henoch Schönlein Purpura Nephritis Associated with Intravesical Bacillus Calmette-Guerin (BCG) Therapy
Sign Up to like & getrecommendations! Published in 2017 at "Internal Medicine"
DOI: 10.2169/internalmedicine.56.7494
Abstract: Henoch Schönlein purpura (HSP), also known as IgA vasculitis (IgAV), is a systemic small-vessel vasculitis that predominantly affects adolescents and is rare in adults. In many cases, the onset of HSP has been causally linked… read more here.
Keywords: henoch sch; bcg therapy; nlein purpura; bacillus calmette ... See more keywords
Gmcsf and Ifnα gene therapy improves the response to BCG immunotherapy in a murine model of bladder cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Future oncology"
DOI: 10.2217/fon-2020-0137
Abstract: Aim: To develop a strategy to improve response to bacillus Calmette-Gueri (BCG) using cytokine gene therapy (Gmcsf + Ifnα). Materials & methods: MB49-PSA tumor-bearing C57BL/6N mice were assigned into four groups: control; Gmcsf + Ifnα… read more here.
Keywords: bcg therapy; gmcsf ifn; gene therapy; therapy ... See more keywords
Bacillus Calmette-Guérin Spondylodiscitis after Intravesical BCG Therapy: A Case Report
Sign Up to like & getrecommendations! Published in 2022 at "Spine Surgery and Related Research"
DOI: 10.22603/ssrr.2022-0009
Abstract: Figure 1-a. Sagittal plane computed tomography (CT) scan at first visit. CT shows osteolytic lesion on T9–T10. The arrow marks T9. Fig. 1-b Sagittal magnetic resonance imaging (MRI) images at first visit. Left: T1-weighted image.… read more here.
Keywords: bcg therapy; calmette rin; intravesical bcg; rin spondylodiscitis ... See more keywords
Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15072002
Abstract: Simple Summary This retrospective cohort study aimed to understand the incidence, clinical impact, and risk factors associated with upper urinary tract urothelial carcinoma (UTUC) after intravesical Bacillus Calmette-Guerin (BCG) therapy. The study included 3226 patients… read more here.
Keywords: bcg therapy; urinary tract; survival; bcg ... See more keywords